Ryan Weight

1.0k total citations
27 papers, 410 citations indexed

About

Ryan Weight is a scholar working on Oncology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Ryan Weight has authored 27 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Ophthalmology. Recurrent topics in Ryan Weight's work include Cancer Immunotherapy and Biomarkers (13 papers), Melanoma and MAPK Pathways (6 papers) and Ocular Oncology and Treatments (6 papers). Ryan Weight is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Melanoma and MAPK Pathways (6 papers) and Ocular Oncology and Treatments (6 papers). Ryan Weight collaborates with scholars based in United States, United Kingdom and India. Ryan Weight's co-authors include John A. Viator, Paul S. Dale, Charles W. Caldwell, Marlana Orloff, Takami Sato, Michael J. Mastrangelo, Mizue Terai, V. Roshan Joseph, Pınar Keskinocak and David Arguello and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ryan Weight

24 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Weight United States 11 176 135 120 75 72 27 410
A Nizze United States 6 231 1.3× 47 0.3× 264 2.2× 165 2.2× 9 0.1× 7 494
Saori Tomita Japan 10 137 0.8× 177 1.3× 109 0.9× 210 2.8× 4 0.1× 12 552
James Freeman Australia 10 417 2.4× 95 0.7× 158 1.3× 268 3.6× 51 0.7× 11 668
Joakim Karlsson Sweden 13 278 1.6× 61 0.5× 176 1.5× 272 3.6× 146 2.0× 24 572
Annette Affolter Germany 16 368 2.1× 64 0.5× 91 0.8× 389 5.2× 9 0.1× 43 716
A. Y. Bedikian United States 10 390 2.2× 28 0.2× 131 1.1× 234 3.1× 61 0.8× 24 524
Annemijn P. A. Wierenga Netherlands 13 121 0.7× 24 0.2× 162 1.4× 146 1.9× 291 4.0× 21 389
H. Drepper Germany 8 537 3.1× 55 0.4× 99 0.8× 208 2.8× 10 0.1× 19 613
Jacob E. Koskimaki United States 14 143 0.8× 38 0.3× 60 0.5× 337 4.5× 41 0.6× 21 545
Jianen Wang China 5 329 1.9× 23 0.2× 348 2.9× 85 1.1× 2 0.0× 8 580

Countries citing papers authored by Ryan Weight

Since Specialization
Citations

This map shows the geographic impact of Ryan Weight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Weight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Weight more than expected).

Fields of papers citing papers by Ryan Weight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Weight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Weight. The network helps show where Ryan Weight may publish in the future.

Co-authorship network of co-authors of Ryan Weight

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Weight. A scholar is included among the top collaborators of Ryan Weight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Weight. Ryan Weight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Soo Jung, David M. Ellison, Ryan Weight, et al.. (2025). CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma. Future Oncology. 21(4). 431–436. 1 indexed citations
2.
Keeling, J. W., et al.. (2025). First report of ROR2 directed therapy with a conditionally active antibody drug conjugate in advanced melanoma.. Journal of Clinical Oncology. 43(16_suppl). 3077–3077.
3.
Butler, Marcus O., Ryan Weight, Rizwan Haq, et al.. (2024). 1139TiP IDE196 (darovasertib) in combination with crizotinib versus investigator’s choice of treatment as first-line therapy in HLA-A2 negative metastatic uveal melanoma. Annals of Oncology. 35. S747–S747. 2 indexed citations
4.
Lacouture, Mario E., Elena Goleva, Neil J. Shah, et al.. (2024). Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways. Clinical Cancer Research. 30(13). 2822–2834. 13 indexed citations
5.
Goleva, Elena, Mario E. Lacouture, Taras Lyubchenko, et al.. (2024). Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses. Journal of Allergy and Clinical Immunology. 153(2). AB227–AB227.
6.
Panella, Timothy J., Sajeve Thomas, Meredith McKean, et al.. (2023). A phase 3 trial comparing fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) to pembrolizumab in patients with completely resected high-risk melanoma.. Journal of Clinical Oncology. 41(16_suppl). TPS9598–TPS9598. 1 indexed citations
7.
Thomas, Anusha Shirwaikar, Seung Eun Lee, Malek Shatila, et al.. (2023). IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience. The American Journal of Gastroenterology. 118(9). 1679–1683. 15 indexed citations
8.
Wilson, Melissa, Larisa J. Geskin, Richard D. Carvajal, et al.. (2021). Adjuvant nivolumab in high-risk stage IIb/IIc melanoma patients: Results from investigator initiated clinical trial.. Journal of Clinical Oncology. 39(15_suppl). 9583–9583. 1 indexed citations
9.
Mukherjee, Nabanita, Carol M. Amato, William A. Robinson, et al.. (2020). Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma. Cancers. 12(8). 2182–2182. 26 indexed citations
10.
Caldararo, Mario, Sheel Patel, Sharon Li, et al.. (2018). Effect of pretreatment steroids on the development of immune related adverse events.. Journal of Clinical Oncology. 36(15_suppl). e15095–e15095. 3 indexed citations
11.
Li, Sharon, Sheel Patel, Mario Caldararo, et al.. (2018). Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review.. Journal of Clinical Oncology. 36(15_suppl). e15069–e15069.
12.
Orloff, Marlana, Ryan Weight, Matías E. Valsecchi, & Takami Sato. (2016). Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?. Reviews on Recent Clinical Trials. 11(2). 81–86. 12 indexed citations
13.
Weight, Ryan, Shingo Sato, Marlana Orloff, Michael J. Mastrangelo, & Takami Sato. (2016). Circulating cell free DNA to predict recurrence in uveal melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9569–9569. 1 indexed citations
14.
Terai, Mizue, Zhaomei Mu, David J. Eschelman, et al.. (2015). Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells. EBioMedicine. 2(11). 1821–1826. 33 indexed citations
15.
Weight, Ryan & John A. Viator. (2013). Detection of Circulating Tumor Cells by Photoacoustic Flowmetry. Methods in molecular biology. 1102. 655–663. 5 indexed citations
16.
Gutı́errez-Juárez, G., et al.. (2010). Optical Photoacoustic Detection of Circulating Melanoma Cells In Vitro. International Journal of Thermophysics. 31(4-5). 784–792. 20 indexed citations
17.
Keskinocak, Pınar, et al.. (2010). Estimating and benchmarking Less-than-Truckload market rates. Transportation Research Part E Logistics and Transportation Review. 46(5). 667–682. 39 indexed citations
18.
Weight, Ryan, Paul S. Dale, & John A. Viator. (2009). Detection of circulating melanoma cells in human blood using photoacoustic flowmetry. PubMed. 2009. 106–109. 27 indexed citations
19.
Dale, Paul S., et al.. (2008). Photoacoustic detection of breast cancer cells in human blood. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6856. 685609–685609. 6 indexed citations
20.
Weight, Ryan, et al.. (2006). Photoacoustic detection of metastatic melanoma cells in the human circulatory system. Optics Letters. 31(20). 2998–2998. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Nizze Breakdown of academic impact, for papers by Saori Tomita Breakdown of academic impact, for papers by James Freeman Breakdown of academic impact, for papers by Joakim Karlsson Breakdown of academic impact, for papers by Annette Affolter Breakdown of academic impact, for papers by A. Y. Bedikian Breakdown of academic impact, for papers by Annemijn P. A. Wierenga Breakdown of academic impact, for papers by H. Drepper Breakdown of academic impact, for papers by Jacob E. Koskimaki Breakdown of academic impact, for papers by Jianen Wang
Rankless by CCL
2026